We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

02 Jun 2025 - 04 Jun 2025
11 Jun 2025 - 13 Jun 2025

DNA Biosensor Enables Early Diagnosis of Cervical Cancer

By LabMedica International staff writers
Posted on 21 Dec 2023

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community. More...

These nanosheets are formed through the stacking of S–Mo–S layers that are held together by Van der Waals forces. MoS2's distinctive structural, optical, thermal, and electrochemical attributes have paved the way for research in diverse domains, including biomolecule sensing, optoelectronics, energy storage, and more. Historically, carbon nanostructures have been used as an immobilization platform for DNA. To replace carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 must be improved significantly.

To tackle this challenge, researchers at Chung-Ang University (Seoul, South Korea) have devised an electrochemical DNA biosensor using a composite of graphitic nano-onions and MoS2 nanosheets. This biosensor shows promise in detecting human papillomavirus (HPV) types 16 and 18, offering the potential for early cervical cancer diagnosis. The team measured the biosensor's sensitivity to these HPV types using the differential pulse voltammetry (DPV) technique in conjunction with methylene blue (MB) as a redox indicator. They observed that the nano-onion/MoS2 nanosheet composite electrode demonstrated higher current peaks than its MoS2-only counterpart, suggesting enhanced conductive electron transfer facilitated by the nano-onions.

This enhancement led to the effective and specific detection of target DNAs from HPV-16 and HPV-18 Siha and Hela cancer cell lines. As a result, MoS2 nanosheets with improved electrical conductivity, when combined with nano-onions, have shown potential as a robust platform for creating electrochemical biosensors that can efficiently diagnose various health conditions, including cervical cancer. Moreover, the integration of nano-onions or nanodiamonds with various organic biomaterials could lead to advancements in chemical functionality, electron transfer conductivity, light absorption, and more. These developments hold promise for groundbreaking applications in disease sensing, targeted drug delivery, and biomedical imaging and diagnostics.

Related Links:
Chung-Ang University 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Uric Acid Meter
PA-16
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The new tool is designed for accurate detection of structural variations in clinical samples (Photo courtesy of Karen Arnott/EMBL-EBI and Isabel Romero Calvo/EMBL)

ML Algorithm Accurately Identifies Cancer-Specific Structural in Long-Read DNA Sequencing Data

Long-read sequencing technologies are designed to analyze long, continuous stretches of DNA, offering significant potential to enhance researchers' abilities to detect complex genetic changes in cancer genomes.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.